Advances in Gerontology is a pivotal academic journal dedicated to the field of gerontology, published by PLEIADES PUBLISHING INC. With its ISSN 2079-0570 and E-ISSN 2079-0589, this journal serves as an essential platform for researchers, healthcare professionals, and students focused on aging and related health issues. Although currently not an open-access journal, it aspires to enrich the scholarly community by disseminating high-quality research from 2011 through 2024. The journal is recognized in the lower quartile of its category, ranking Q4 in both Geriatrics and Gerontology, reflecting its commitment to addressing emerging topics in the aging population despite its lower visibility in the competitive landscape. As it continues to explore critical areas in gerontology, Advances in Gerontology invites contributions that advance knowledge, foster understanding, and inform practices within this essential field of study.

DRUGS & THERAPY PERSPECTIVES is an esteemed journal published by SpringerNature, dedicated to advancing knowledge in the field of pharmacology and therapeutic studies. With an ISSN of 1172-0360 and an E-ISSN of 1179-1977, this journal has been providing valuable insights since its inception in 1993 and continues to publish until 2024. Ranked in the Q3 category for Pharmacology (medical) and positioned within the 25th percentile according to Scopus rankings, it serves as a vital resource for researchers, practitioners, and students alike. Although it is not an open-access journal, it offers a comprehensive platform for innovative research, clinical practices, and evolving therapeutic strategies, reflecting the critical developments in drug therapy landscape. With its strategic emphasis on bridging academic studies and clinical applications, DRUGS & THERAPY PERSPECTIVES remains essential for those committed to enhancing drug efficacy and patient outcomes in the ever-evolving medical field.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, published by Wiley, stands as a leading resource in the field of geriatrics and gerontology. Established in 1953 and converging into a comprehensive academic platform through 2024, this esteemed journal is recognized for its high impact, holding a Q1 ranking in its category for 2023. It serves as a vital conduit for innovative research, clinical practices, and policy discussions aimed at improving the health and well-being of older adults. With a commitment to advancing geriatric medicine, the journal contributes significantly to the ongoing dialogue among researchers, healthcare professionals, and students dedicated to this rapidly evolving field. Although currently not offering open access options, the journal remains invaluable for those seeking to access pivotal studies and reviews that shape the future of geriatrics.

PHARMAZIE is a prestigious, peer-reviewed journal published by AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBH, focusing on the dynamic field of pharmaceutical science since its inception in 1947. With its ISSN 0031-7144 and a current impact factor placing it in the Q2 category of Pharmaceutical Science journals, PHARMAZIE has established itself as a pivotal resource for researchers, practitioners, and students alike. The journal emphasizes the dissemination of high-quality, original research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of knowledge and innovation in these fields. While currently not open access, the journal maintains a commendable Scopus rank of #94 out of 183 in its category, highlighting its relevance and appeal to the academic community. With a commitment to bridging the gap between research and practical applications, PHARMAZIE plays a crucial role in shaping the future of pharmaceutical practices and policies.

Welcome to the European Journal of Geriatrics and Gerontology, a peer-reviewed platform dedicated to advancing knowledge and research in the fields of geriatrics and gerontology. Published by GALENOS PUBL HOUSE, this journal serves as a critical resource for researchers, healthcare professionals, and students who are involved in the care, treatment, and study of elderly populations. Since its inception in 2019 and running through 2024, the journal aims to foster interdisciplinary collaboration and disseminate innovative research that addresses the unique challenges faced by older adults. With an ISSN of 2687-2625, the journal is classified in the Q4 quartile of the Geriatrics and Gerontology category, signifying its emerging influence within the academic community, despite its current Scopus ranking of #113 out of 116, reflecting a rich opportunity for growth and visibility. Although the journal is not open access, it maintains a commitment to scholarly rigor and quality. Engage with the European Journal of Geriatrics and Gerontology to contribute to and learn from the evolving discourse in aging research.

Canadian Geriatrics Journal, published by MULTIMED INC, is a prominent platform dedicated to advancing the field of geriatrics and gerontology. With its esteemed status as a Q2 journal in both Geriatrics and Gerontology categories for 2023, it ranks favorably within the academic community, holding a 73rd percentile in Nursing Gerontology and a 59th percentile in Medicine Geriatrics and Gerontology according to Scopus metrics. Since its inception in 2011, the journal has aimed to foster innovation and disseminate pivotal research that addresses the complexities of aging populations. Researchers, healthcare professionals, and students interested in the intricacies of geriatric care will find a wealth of open-access resources that contribute significantly to enhancing practice and care methodologies in Canada and beyond. With its address located at 66 Martin St, Toronto, ON L9T 2R2, Canada, the journal stands as a vital resource for stakeholders in the geriatric field.

ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, published by SPRINGER HEIDELBERG, is an authoritative journal dedicated to advancing the field of geriatrics and gerontology. With its ISSN 0948-6704 and E-ISSN 1435-1269, this journal has been a significant source of scholarly articles since its inception in 1995, catering to researchers and practitioners amid the growing importance of ageing studies. While it currently holds a Q4 ranking in Geriatrics and Gerontology and a Q3 ranking in Gerontology and Social Sciences, its contribution spans vital topics related to health ethics and legal aspects—reflecting a comprehensive view of the challenges faced in elder care. Although it is not an open-access journal, its rigorous peer-review process ensures that the research published is of high quality and relevance. Based in Heidelberg, Germany, the journal aims to foster discourse and disseminate crucial research findings that impact the health of elderly populations, making it an essential resource for researchers, healthcare professionals, and students devoted to improving geriatric care and understanding the complexities associated with ageing.

Expert Opinion on Drug Safety is a prestigious academic journal dedicated to advancing knowledge in the fields of drug safety and pharmacology. Published by Taylor & Francis Ltd, this journal serves as an essential resource for researchers and professionals seeking to explore the complexities of drug interactions, adverse effects, and risk management. With an impressive impact factor and recognized as a Q1 journal in both the Medicine (Miscellaneous) and Pharmacology (Medical) categories, it ranks favorably at #78 out of 272 in Scopus, placing it in the 71st percentile among its peers. Operating under a rigorous peer-review process, the journal publishes original research, expert reviews, and opinion pieces that contribute to a deeper understanding of drug safety practices. While not an open access journal, it remains a vital platform for disseminating pivotal findings and fostering scholarly dialogue, ensuring that critical insights reach a global audience. With continuous publication from 2002 to 2024, Expert Opinion on Drug Safety is a key reference for anyone involved in pharmaceutical research, healthcare practice, or drug regulation.

Journal of Gerontology and Geriatrics, published by PACINI EDITORE, is a crucial resource for those dedicated to the study of aging and geriatric health. Since its inception in 2016, this journal has aimed to disseminate high-quality research and findings that address the intricate biological, social, and psychological aspects of aging. With ISSN 2499-6564 and E-ISSN 2499-6564, it strives to foster discussions that enhance our understanding of gerontology and geriatrics on a global scale, despite its current positioning in the Q4 quartile of academic rankings. Located in Pisa, Italy, the journal invites contributions from researchers, professionals, and students who are passionate about advancing knowledge in these critical fields. Although it currently does not offer open access, the journal plays a vital role in connecting the community with essential insights that guide both research and practice in geriatric care.

Drug Healthcare and Patient Safety is a premier Open Access journal, published by DOVE MEDICAL PRESS LTD since 2009, dedicated to advancing the understanding and practices surrounding medication safety and healthcare delivery. With its ISSN 1179-1365 and E-ISSN matching, this New Zealand-based journal not only fosters global discourse but also prioritizes the dissemination of research that intersects both health policy and pharmacology. Categorized as Q2 in Health Policy and Q3 in Pharmacology for the year 2023, it occupies a notable position within the academic community, as reflected by its Scopus rankings, which place it in the 66th and 45th percentiles of its respective categories. Drug Healthcare and Patient Safety aims to provide a platform for researchers, practitioners, and students to share innovative findings, promote safe medication practices, and explore the implications of health policy on patient outcomes. As an Open Access journal, it ensures that vital research is accessible to a wider audience, making significant contributions to the ongoing dialogue in the fields of healthcare and pharmacovigilance.